Fortinet Inc. Stock Sheds 4.5%, Underperforms Market
Dow Jones2026/09/02 20:34This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Fortinet Inc. slid 4.5% to $154.54 on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.5% to 7,666.60 and the Dow Jones Industrial Average rising 0.6% to 53,061.95.
This was the stock's second consecutive day of losses.
Fortinet Inc. closed 11.1% below its 52-week high of $173.89, which the company reached on August 27th.
The stock demonstrated a mixed performance when compared to some of its peers, as Cisco Systems Inc. fell 0.3% to $109.46, CrowdStrike Holdings Inc. Cl A fell 5.4% to $203.42, and Palo Alto Networks Inc. fell 9.28% to $328.48.
Trading volume totaled 5.2 million, compared to the 50-day average of 5.2 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
September 02, 2026 16:34 ET (20:34 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Janus Henderson Macro Head Says Market Is Near Its Top but Cannot Say When
A $5.7 billion patent verdict has been issued, Burford Capital (BUR.US) may receive $1.4 billion, and its share price soared by more than 12%.
Burford Capital Ltd. surged more than 12% on Monday, marking its largest intraday increase since the end of March, after a federal jury delivered a verdict in a patent case involving Apple.
Pfizer (PFE.US), BioNTech (BNTX.US), and Moderna (MRNA.US) seek dismissal of Bayer’s Monsanto mRNA patent lawsuit, but the judge rejects the request
A federal judge in Delaware on Monday rejected the requests from Pfizer, BioNTech, and Moderna to dismiss a lawsuit filed against them by Monsanto, a subsidiary of the German pharmaceutical giant Bayer. The lawsuit concerns these pharmaceutical companies' use of a patent related to mRNA technology.
After years of waiting and another delay, Tesla (TSLA.US) postpones the Roadster debut to October 15 as severe weather forces the event to stop.
Tesla has rescheduled the unveiling event for its next-generation Roadster, originally planned for this week, to October 15.
Crypto prices
More
